SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000912282-07-000324
Filing Date
2007-03-19
Accepted
2007-03-19 17:26:27
Documents
11
Period of Report
2006-03-17

Document Format Files

Seq Description Document Type Size
1 oncolytics6k_03162007.htm 6-K 17882
2 GRAPHIC ballot.jpg GRAPHIC 751
3 GRAPHIC ballotx.jpg GRAPHIC 762
4 GRAPHIC img1.gif GRAPHIC 145
5 GRAPHIC img2.gif GRAPHIC 166
6 GRAPHIC img3.gif GRAPHIC 174
7 ex_1.htm EX-1 702
8 GRAPHIC ex1.jpg GRAPHIC 61060
9 ex_2.htm EX-2 4876
10 GRAPHIC img1.jpg GRAPHIC 1741
11 ex_3.htm EX-3 3641
  Complete submission text file 0000912282-07-000324.txt   118733
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 07704325
SIC: 2834 Pharmaceutical Preparations